Abstract:Background: The progression of Biliary Atresia (BA) is associated with the number of reactive ductular cells (RDCs) whose heterogeneity in origin and evolution in humans remains unknown. SOX9-positive liver progenitor-like cells (LPLCs) have been shown to participate in RDCs and new hepatocyte formation during cholestatic liver regeneration in an animal model, which implies the possibility that hepatocyte-reprogrammed LPLCs could be a source of RDCs in BA. The present study aimed to elucidate the characteristics of SOX9-positive LPLCs in BA for exploring new possible therapeutic targets by manipulating the bi-differentiation process of LPLCs to prevent disease progression. Methods: Twenty-eight patients, including 24 patients with BA and 4 patients with Congenital Choledochal Cyst as the control group, were retrospectively recruited. Liver biopsy samples were classified histologically using a 4-point scale based on fibrosis severity. LPLCs were detected by SOX9 and HNF4A double positive staining. Single immunohistochemistry, double immunohistochemistry, and multiple immunofluorescence staining were used to determine the different cell types and characteristics of LPLCs. Results: The prognostic predictors of BA, namely total bile acid (TBA), RDCs, and fibrosis, were correlated to the emergence of LPLCs. SOX9 and HNF4A double-positive LPLCs co-stained rarely with relevant markers of portal hepatic progenitor cells (portal-HPCs), including CK19, CK7, EPCAM, PROM1 (CD133), TROP2, and AFP. Under cholestasis conditions, LPLCs acquired superior proliferation and anti-senescence ability among hepatocytes. Moreover, LPLCs arranged as a pseudo-rosette structure appeared from the periportal parenchyma to the portal region, which implied the differentiation from hepatocyte-reprogrammed LPLCs to RDCs with the progression of cholestasis. Conclusions: LPLCs are associated with disease progression and prognostic factors of BA. The bipotent characteristics of LPLCs are different from those of portal-HPCs. As cholestasis progresses, LPLCs appear to gain superior proliferation and anti-senescence ability and continually differentiate to RDCs.

Biliary stem cells in health and cholangiopathies and cholangiocarcinoma

The diversity and plasticity of adult hepatic progenitor cells and their niche

Exploiting the plasticity of cholangiocytes to repair the biliary tree

The role of progenitor cells in repair of liver injury and in liver transplantation

Development of the bile ducts: Essentials for the clinical hepatologist

In VitroandIn VivoHepatic Differentiation of Adult Somatic Stem Cells and Extraembryonic Stem Cells for Treating End Stage Liver Diseases

In Vitro Culture of Isolated Primary Hepatocytes and Stem Cell-Derived Hepatocyte-Like Cells for Liver Regeneration

Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver

Liver stem cells: basic research and clinical significance]

Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration

Cholangiocyte organoids can repair bile ducts after transplantation in the human liver

The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies

Recent advances in tissue stem cells

Characteristics of SOX9-positive progenitor-like cells during cholestatic liver regeneration in biliary atresia

Current Strategies to Generate Mature Human Induced Pluripotent Stem Cells Derived Cholangiocytes and Future Applications

Central role for cholangiocyte pathobiology in cholestatic liver diseases

Human branching cholangiocyte organoids recapitulate functional bile duct formation

Implication for Bone Marrow Derived Stem Cells in Hepatocyte Regeneration after Orthotopic Liver Transplantation

Regional Differences in Human Biliary Tissues and Corresponding In Vitro –Derived Organoids

Liver regeneration: biological and pathological mechanisms and implications

Stem-Like Cells In Hepatitis B Virus-Associated Cirrhotic Livers And Adjacent Tissue To Hepatocellular Carcinomas Possess The Capacity Of Tumorigenicity